Evaluation of an Altered Peptide Ligand (NBI-5788) in Patients With Relapsing Multiple Sclerosis (MS)

This study has been completed.
Sponsor:
Collaborator:
Immune Tolerance Network (ITN)
Information provided by:
Neurocrine Biosciences
ClinicalTrials.gov Identifier:
NCT00079495
First received: March 8, 2004
Last updated: March 20, 2008
Last verified: September 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: April 2005
  Estimated Primary Completion Date: No date given